Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 EUR | 0.00% |
|
+2.88% | 0.00% |
Jul. 01 | New semester, new state of mind | ![]() |
Jun. 26 | DSM-Firmenich Unit Issues EUR800 Million Bond | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 61.54 and 36.33 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 31.92B | - | ||
+15.93% | 903B | D+ | ||
+3.08% | 246B | - | C | |
+26.87% | 177B | B | ||
+2.45% | 140B | B- | ||
+81.96% | 110B | B+ | ||
-8.30% | 71.67B | B | ||
-5.57% | 57.12B | C+ | ||
+123.70% | 38.89B | B- | ||
+38.87% | 37.4B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DSFIR Stock
- ZX61 Stock
- Ratings DSM-Firmenich AG